Table 4 lists the low-dose combinations currently available for the treatment of hypertension. Two low-dose combination ... It will be noticed that this list of advantages of low-dose combination ...

Breathing exercises help lower blood pressure by slowing down your breathing and stimulating the vagus nerve, which controls ...

Glaukos' iDose TR achieves lasting IOP reduction and safety, transforming glaucoma treatment. The company is progressing well ...

For those looking to attain a healthy body weight in 2025, there are a few options to consider. Dr. Will Cauthen, a ...

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

Unfortunately, most New Year’s resolutions fail. A 2023 Forbes poll found that 44% of resolutions last just two to three ...

In later stages, the consequences of portal hypertension ... waiting list for liver transplantation and in individuals with complete cirrhosis and absent inflammatory activity, treatment does ...

Surprisingly, they discovered that ACE inhibitors were the first choice for nearly half of the patients, while only 17% were ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

We have been discussing and researching maternal health disparities for over 20 years. Has Cayaba Care found an answer?

The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Roivant Sciences Ltd.